Literature DB >> 21475359

The epidemiology of giant cell arteritis in Otago, New Zealand: a 9-year analysis.

Anmar M Abdul-Rahman1, Anthony C B Molteno, Tui H Bevin.   

Abstract

AIMS: To study the epidemiology of biopsy proven giant cell arteritis (GCA) in patients in the Otago region, New Zealand.
MATERIALS AND METHODS: Records of 363 consecutive patients who underwent temporal artery biopsy at Dunedin Hospital between 1996–2005 were reviewed. Annual incidence of biopsy-proven GCA was estimated, epidemiologic characteristics of the biopsy-positive group was compared with the biopsy-negative group.
RESULTS: Among the 363 patients who underwent temporal artery biopsy there were 105 (29%) males and 258 (71%) females; biopsy-proven GCA was diagnosed in 70 (19%) patients. The mean age of biopsy-positive group was 72.8 years (range 57-91 years, SD 8.2), which was comparable to the biopsy-negative group 73.4 years (range 50–97 years, SD 9.5), p<0.2. The mean annual incidence of GCA in Otago was 12.73/100,000 CI (11.7–14.3, p<0.5) for patients ≥50 years over the 9 years of observation.
CONCLUSIONS: The first large study of GCA from Australasia demonstrated that a variation in the annual incidence rate for giant cell arteritis in Otago, New Zealand showed a cyclic pattern. The overall incidence seems to reflect the ethnic origins of the majority of the population from Britain.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21475359

Source DB:  PubMed          Journal:  N Z Med J        ISSN: 0028-8446


  9 in total

1.  Giant cell arteritis in patients of Indian Subcontinental descent in the UK.

Authors:  N Tan; J Acheson; N Ali
Journal:  Eye (Lond)       Date:  2018-10-12       Impact factor: 3.775

2.  The incidence of giant cell arteritis in Olmsted County, Minnesota, over a 60-year period 1950-2009.

Authors:  A K Chandran; P D Udayakumar; C S Crowson; K J Warrington; E L Matteson
Journal:  Scand J Rheumatol       Date:  2015-01-21       Impact factor: 3.641

Review 3.  Large-vessel vasculitis.

Authors:  Dan Pugh; Maira Karabayas; Neil Basu; Maria C Cid; Ruchika Goel; Carl S Goodyear; Peter C Grayson; Stephen P McAdoo; Justin C Mason; Catherine Owen; Cornelia M Weyand; Taryn Youngstein; Neeraj Dhaun
Journal:  Nat Rev Dis Primers       Date:  2022-01-06       Impact factor: 65.038

4.  Diagnostic use of ultrasound in giant cell arteritis in Counties Manukau District Health Board, New Zealand.

Authors:  Rathan Nagarajah; Rajiv Gupta; Sunil Kumar
Journal:  Rheumatol Adv Pract       Date:  2022-05-12

Review 5.  Vasculitis in New Zealand.

Authors:  Janak Rashme de Zoysa
Journal:  Clin Exp Nephrol       Date:  2012-11-23       Impact factor: 2.801

6.  Geo-epidemiology of temporal artery biopsy-positive giant cell arteritis in Australia and New Zealand: is there a seasonal influence?

Authors:  Elisabeth De Smit; Linda Clarke; Paul G Sanfilippo; Tony R Merriman; Matthew A Brown; Catherine L Hill; Alex W Hewitt
Journal:  RMD Open       Date:  2017-08-29

7.  Ultrasound versus temporal artery biopsy in patients with Giant cell arteritis: a prospective cohort study.

Authors:  Quan Zou; Sumei Ma; Xinghu Zhou
Journal:  BMC Med Imaging       Date:  2019-06-06       Impact factor: 1.930

8.  Does herpes zoster predispose to giant cell arteritis: a geo-epidemiologic study.

Authors:  Edsel B Ing; Royce Ing; Xinyang Liu; Angela Zhang; Nurhan Torun; Michael Sey; Christian Pagnoux
Journal:  Clin Ophthalmol       Date:  2018-01-11

9.  Incidence of giant cell arteritis in Western Norway 1972-2012: a retrospective cohort study.

Authors:  L K Brekke; A P Diamantopoulos; B-T Fevang; J Aβmus; E Esperø; C G Gjesdal
Journal:  Arthritis Res Ther       Date:  2017-12-15       Impact factor: 5.156

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.